Results 11 to 20 of about 39,899 (305)

Intra-arterial PSMA injection using hepatic arterial infusion pump in intrahepatic cholangiocarcinoma: a proof-of-concept study [PDF]

European Radiology Experimental
Prostate-specific membrane antigen (PSMA) targeted tracers show increased uptake in several malignancies, indicating a potential for peptide radioligand therapy. Intra-arterial injection of radiotracers can increase the therapeutic window.
Mara Marieke Katrien Veenstra, Erik Vegt, Marcel Segbers, Stijn Franssen, Bas Groot Koerkamp, Frederik Anton Verburg, Maarten Guillaume Josephus Thomeer   +6 more
doaj   +2 more sources

Intrahepatic cholangiocarcinoma: current perspectives [PDF]

OncoTargets and Therapy, 2017
Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy arising from the liver. ICC makes up about 10% of all cholangiocarcinomas. It arises from the peripheral bile ducts within the liver parenchyma, proximal to the secondary biliary radicals. Histologically, the majority of ICCs are adenocarcinomas. Only a minority of patients (15%)
Stefan Buettner, Jeroen L.A. van Vugt, Jan IJzermans, Bas Groot Koerkamp   +3 more
openaire   +6 more sources

Sarcomatoid Intrahepatic Cholangiocarcinoma: A Case Report [PDF]

Advanced Ultrasound in Diagnosis and Therapy, 2023
Conventional two-dimensional ultrasonography revealed a hypoechoic mass in the liver of a middle-aged male patient. Enhanced ultrasound suggested intrahepatic cholangiocarcinoma. Enhanced MRI confirmed it as liver cancer.
Cuiwei Wang, MD, Xin-Hua Ye, MD
doaj   +1 more source

Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma With a High Tumor Mutational Burden and PD-L1 Expression by PD-1 Blockade Combined With Tyrosine Kinase Inhibitors: A Case Report

Frontiers in Immunology, 2021
Advanced intrahepatic cholangiocarcinoma (iCCA) is not suitable for surgical treatment. Guided by the concept of precision medicine, preoperative systematic treatment may reshape the clinical outcomes of advanced intrahepatic cholangiocarcinoma patients.
Ze Zhang, Ze Zhang, Ze Zhang, Ze Zhang, Wenwen Zhang, Wenwen Zhang, Wenwen Zhang, Hongguang Wang, Bingyang Hu, Bingyang Hu, Bingyang Hu, Zhanbo Wang, Shichun Lu, Shichun Lu, Shichun Lu   +14 more
doaj   +1 more source

Intrahepatic mucinous cholangiocarcinoma [PDF]

The Kaohsiung Journal of Medical Sciences, 2020
Bor‐Yow Lin, Chun‐Chieh Wu, Tzu‐Hsueh Tsai   +2 more
openaire   +3 more sources

The VEGF expression associated with prognosis in patients with intrahepatic cholangiocarcinoma: a systematic review and meta-analysis

World Journal of Surgical Oncology, 2022
Objective To systematically evaluate the relationship between vascular endothelial growth factor (VEGF) and prognosis of intrahepatic cholangiocarcinoma by meta-analysis.
Chunping Cai, Xiaoji Wang, Qiurong Fu, Ai Chen   +3 more
doaj   +1 more source

LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis

BMC Cancer, 2021
Background Cholangiocarcinoma is a common malignant tumor of digestive system. LncRNA metallothionein 1 J, pseudogene (MT1JP) has been reported to play tumor-suppressing roles in multiple cancers.
Wei Zhao, Jing Zhao, Xiao Guo, Yujie Feng, Bingyuan Zhang, Lantian Tian   +5 more
doaj   +1 more source

Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses

Journal of Hematology & Oncology, 2022
Background Immunotherapy has demonstrated a limited clinical efficacy in approximately 5% of cholangiocarcinoma. The main challenges for an effective immunotherapy response in cholangiocarcinoma arise from the tumor microenvironment, which is poorly ...
Tao Xia, Keyu Li, Nan Niu, Yingkuan Shao, Ding Ding, Dwayne L. Thomas, Hao Jing, Kenji Fujiwara, Haijie Hu, Arsen Osipov, Chunhui Yuan, Christopher L. Wolfgang, Elizabeth D. Thompson, Robert A. Anders, Jin He, Yiping Mou, Adrian G. Murphy, Lei Zheng   +17 more
doaj   +1 more source

Novel Targeted Therapies for Advanced Cholangiocarcinoma

Medicina, 2021
Cholangiocarcinoma (CCA) includes a group of rare and aggressive hepatobiliary malignancies, including extrahepatic cholangiocarcinoma (eCCA) and intrahepatic cholangiocarcinoma (iCCA), with the former further subdivided into distal (dCCA) and perihilar ...
Alessandro Rizzo, Giovanni Brandi
doaj   +1 more source

Clinically unsuspected primary hepatic mucosa-associated lymphoid tissue lymphoma collision with an intrahepatic cholangiocarcinoma: A case report and literature review

SAGE Open Medical Case Reports, 2021
A synchronous tumor represents two histologically distinct neoplasms occurring at the same anatomic site, each displaying a distinct tumorigenesis pathway; they can be primary, secondary, or a mixture. The occurrence of an adenocarcinoma and lymphoma has
Stefanie Grewe, Mohammad Shahid, Ling Zhang, Kun Jiang   +3 more
doaj   +1 more source